1292 related articles for article (PubMed ID: 19076647)
1. Correlation of increase in phosphene threshold with reduction of migraine frequency: observation of levetiracetam-treated subjects.
Young W; Shaw J; Bloom M; Gebeline-Myers C
Headache; 2008; 48(10):1490-8. PubMed ID: 19076647
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
3. Levetiracetam in the prophylaxis of migraine with aura: a 6-month open-label study.
Brighina F; Palermo A; Aloisio A; Francolini M; Giglia G; Fierro B
Clin Neuropharmacol; 2006; 29(6):338-42. PubMed ID: 17095897
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
[TBL] [Abstract][Full Text] [Related]
5. Modulation of visual cortex excitability in migraine with aura: effects of valproate therapy.
Palermo A; Fierro B; Giglia G; Cosentino G; Puma AR; Brighina F
Neurosci Lett; 2009 Dec; 467(1):26-9. PubMed ID: 19800389
[TBL] [Abstract][Full Text] [Related]
6. Visual cortex excitability in migraine evaluated by single and paired magnetic stimuli.
Gerwig M; Niehaus L; Kastrup O; Stude P; Diener HC
Headache; 2005; 45(10):1394-9. PubMed ID: 16324172
[TBL] [Abstract][Full Text] [Related]
7. Higher variability of phosphene thresholds in migraineurs than in controls: a consecutive transcranial magnetic stimulation study.
Antal A; Arlt S; Nitsche MA; Chadaide Z; Paulus W
Cephalalgia; 2006 Jul; 26(7):865-70. PubMed ID: 16776703
[TBL] [Abstract][Full Text] [Related]
8. Transcranial direct current stimulation reveals inhibitory deficiency in migraine.
Chadaide Z; Arlt S; Antal A; Nitsche MA; Lang N; Paulus W
Cephalalgia; 2007 Jul; 27(7):833-9. PubMed ID: 17498207
[TBL] [Abstract][Full Text] [Related]
9. Migraine-linked characteristics of transcranial magnetic stimulation-induced phosphenes.
Ekkert A; Noreikaitė K; Valiulis V; Ryliškienė K
J Integr Neurosci; 2019 Dec; 18(4):463-466. PubMed ID: 31912706
[TBL] [Abstract][Full Text] [Related]
10. Consecutive transcranial magnetic stimulation: phosphene thresholds in migraineurs and controls.
Young WB; Oshinsky ML; Shechter AL; Gebeline-Myers C; Bradley KC; Wassermann EM
Headache; 2004 Feb; 44(2):131-5. PubMed ID: 14756850
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
[TBL] [Abstract][Full Text] [Related]
12. Interictal cortical excitability in migraine: a study using transcranial magnetic stimulation of motor and visual cortices.
Afra J; Mascia A; Gérard P; Maertens de Noordhout A; Schoenen J
Ann Neurol; 1998 Aug; 44(2):209-15. PubMed ID: 9708543
[TBL] [Abstract][Full Text] [Related]
13. Visual cortex excitability in migraine with and without aura.
Mulleners WM; Chronicle EP; Palmer JE; Koehler PJ; Vredeveld JW
Headache; 2001 Jun; 41(6):565-72. PubMed ID: 11437892
[TBL] [Abstract][Full Text] [Related]
14. Dextroamphetamine pilot crossover trials and n of 1 trials in patients with chronic tension-type and migraine headache.
Haas DC; Sheehe PR
Headache; 2004; 44(10):1029-37. PubMed ID: 15546268
[TBL] [Abstract][Full Text] [Related]
15. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
[TBL] [Abstract][Full Text] [Related]
16. Modulation of visual cortical excitability in migraine with aura: effects of 1 Hz repetitive transcranial magnetic stimulation.
Brighina F; Piazza A; Daniele O; Fierro B
Exp Brain Res; 2002 Jul; 145(2):177-81. PubMed ID: 12110957
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
Schreiber CP; Cady RK
Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
[TBL] [Abstract][Full Text] [Related]
18. Phosphene thresholds evoked with single and double TMS pulses.
Kammer T; Baumann LW
Clin Neurophysiol; 2010 Mar; 121(3):376-9. PubMed ID: 20079689
[TBL] [Abstract][Full Text] [Related]
19. Migraine changes with age: IMPACT on migraine classification.
Kelman L
Headache; 2006; 46(7):1161-71. PubMed ID: 16866720
[TBL] [Abstract][Full Text] [Related]
20. Spreading photoparoxysmal EEG response is associated with an abnormal cortical excitability pattern.
Siniatchkin M; Groppa S; Jerosch B; Muhle H; Kurth C; Shepherd AJ; Siebner H; Stephani U
Brain; 2007 Jan; 130(Pt 1):78-87. PubMed ID: 17121743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
